Global Radiopharmaceutical Sales Market Report 2021

Name: Global Radiopharmaceutical Sales Market
Brand: Stats And Research
SKU: Healthcare
Price: 2800 USD
Availability: InStock
Rating: 4.2 (20 reviews)

Published Date : 09-07-2021
Pages : 119
Report Id : 13139
Categories : Healthcare

This report studies the global Radiopharmaceutical market status and forecast, categorizes the global Radiopharmaceutical market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2020. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

The global Radiopharmaceutical market is valued at 4940 million US$ in 2020 and will reach 9520 million US$ by the end of 2027, growing at a CAGR of 8.6% during 2021-2027.

The major players covered in this report
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Oncology
Cardiology
Other

The study objectives of this report are:
To analyze and study the global Radiopharmaceutical sales, value, status (2016-2020) and forecast (2021-2027);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Radiopharmaceutical players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Radiopharmaceutical are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Radiopharmaceutical Manufacturers
Radiopharmaceutical Distributors/Traders/Wholesalers
Radiopharmaceutical Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Radiopharmaceutical market, by end-use.
Detailed analysis and profiles of additional market players.
End of Summary

Table of Contents

Global Radiopharmaceutical Sales Market Report 2021
1 Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Classification of Radiopharmaceutical by Product Category
1.2.1 Global Radiopharmaceutical Market Size (Sales) Comparison by Type (2016 - 2027)
1.2.2 Global Radiopharmaceutical Market Size (Sales) Market Share by Type (Product Category) in 2020
1.2.3 Actinium - 225
1.2.4 Lutetium - 177
1.2.5 Radium - 223
1.2.6 Holmium - 166
1.2.7 Other
1.3 Global Radiopharmaceutical Market by Application/End Users
1.3.1 Global Radiopharmaceutical Sales (Volume) and Market Share Comparison by Application (2016 - 2027)
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Global Radiopharmaceutical Market by Region
1.4.1 Global Radiopharmaceutical Market Size (Value) Comparison by Region (2016 - 2027)
1.4.2 United States Radiopharmaceutical Status and Prospect (2016 - 2027)
1.4.3 Europe Radiopharmaceutical Status and Prospect (2016 - 2027)
1.4.4 China Radiopharmaceutical Status and Prospect (2016 - 2027)
1.4.5 Japan Radiopharmaceutical Status and Prospect (2016 - 2027)
1.4.6 Southeast Asia Radiopharmaceutical Status and Prospect (2016 - 2027)
1.4.7 India Radiopharmaceutical Status and Prospect (2016 - 2027)
1.5 Global Market Size (Value and Volume) of Radiopharmaceutical (2016 - 2027)
1.5.1 Global Radiopharmaceutical Sales and Growth Rate (2016 - 2027)
1.5.2 Global Radiopharmaceutical Revenue and Growth Rate (2016 - 2027)

2 Global Radiopharmaceutical Competition by Players/Suppliers, Type and Application
2.1 Global Radiopharmaceutical Market Competition by Players/Suppliers
2.1.1 Global Radiopharmaceutical Sales and Market Share of Key Players/Suppliers (2016 - 2021)
2.1.2 Global Radiopharmaceutical Revenue and Share by Players/Suppliers (2016 - 2021)
2.2 Global Radiopharmaceutical (Volume and Value) by Type
2.2.1 Global Radiopharmaceutical Sales and Market Share by Type (2016 - 2021)
2.2.2 Global Radiopharmaceutical Revenue and Market Share by Type (2016 - 2021)
2.3 Global Radiopharmaceutical (Volume and Value) by Region
2.3.1 Global Radiopharmaceutical Sales and Market Share by Region (2016 - 2021)
2.3.2 Global Radiopharmaceutical Revenue and Market Share by Region (2016 - 2021)
2.4 Global Radiopharmaceutical (Volume) by Application

3 United States Radiopharmaceutical (Volume, Value and Sales Price)
3.1 United States Radiopharmaceutical Sales and Value (2016 - 2021)
3.1.1 United States Radiopharmaceutical Sales and Growth Rate (2016 - 2021)
3.1.2 United States Radiopharmaceutical Revenue and Growth Rate (2016 - 2021)
3.1.3 United States Radiopharmaceutical Sales Price Trend (2016 - 2021)
3.2 United States Radiopharmaceutical Sales Volume and Market Share by Players (2016 - 2021)
3.3 United States Radiopharmaceutical Sales Volume and Market Share by Type (2016 - 2021)
3.4 United States Radiopharmaceutical Sales Volume and Market Share by Application (2016 - 2021)

4 Europe Radiopharmaceutical (Volume, Value and Sales Price)
4.1 Europe Radiopharmaceutical Sales and Value (2016 - 2021)
4.1.1 Europe Radiopharmaceutical Sales and Growth Rate (2016 - 2021)
4.1.2 Europe Radiopharmaceutical Revenue and Growth Rate (2016 - 2021)
4.1.3 Europe Radiopharmaceutical Sales Price Trend (2016 - 2021)
4.2 Europe Radiopharmaceutical Sales Volume and Market Share by Players (2016 - 2021)
4.3 Europe Radiopharmaceutical Sales Volume and Market Share by Type (2016 - 2021)
4.4 Europe Radiopharmaceutical Sales Volume and Market Share by Application (2016 - 2021)

5 China Radiopharmaceutical (Volume, Value and Sales Price)
5.1 China Radiopharmaceutical Sales and Value (2016 - 2021)
5.1.1 China Radiopharmaceutical Sales and Growth Rate (2016 - 2021)
5.1.2 China Radiopharmaceutical Revenue and Growth Rate (2016 - 2021)
5.1.3 China Radiopharmaceutical Sales Price Trend (2016 - 2021)
5.2 China Radiopharmaceutical Sales Volume and Market Share by Players (2016 - 2021)
5.3 China Radiopharmaceutical Sales Volume and Market Share by Type (2016 - 2021)
5.4 China Radiopharmaceutical Sales Volume and Market Share by Application (2016 - 2021)

6 Japan Radiopharmaceutical (Volume, Value and Sales Price)
6.1 Japan Radiopharmaceutical Sales and Value (2016 - 2021)
6.1.1 Japan Radiopharmaceutical Sales and Growth Rate (2016 - 2021)
6.1.2 Japan Radiopharmaceutical Revenue and Growth Rate (2016 - 2021)
6.1.3 Japan Radiopharmaceutical Sales Price Trend (2016 - 2021)
6.2 Japan Radiopharmaceutical Sales Volume and Market Share by Players (2016 - 2021)
6.3 Japan Radiopharmaceutical Sales Volume and Market Share by Type (2016 - 2021)
6.4 Japan Radiopharmaceutical Sales Volume and Market Share by Application (2016 - 2021)

7 Southeast Asia Radiopharmaceutical (Volume, Value and Sales Price)
7.1 Southeast Asia Radiopharmaceutical Sales and Value (2016 - 2021)
7.1.1 Southeast Asia Radiopharmaceutical Sales and Growth Rate (2016 - 2021)
7.1.2 Southeast Asia Radiopharmaceutical Revenue and Growth Rate (2016 - 2021)
7.1.3 Southeast Asia Radiopharmaceutical Sales Price Trend (2016 - 2021)
7.2 Southeast Asia Radiopharmaceutical Sales Volume and Market Share by Players (2016 - 2021)
7.3 Southeast Asia Radiopharmaceutical Sales Volume and Market Share by Type (2016 - 2021)
7.4 Southeast Asia Radiopharmaceutical Sales Volume and Market Share by Application (2016 - 2021)

8 India Radiopharmaceutical (Volume, Value and Sales Price)
8.1 India Radiopharmaceutical Sales and Value (2016 - 2021)
8.1.1 India Radiopharmaceutical Sales and Growth Rate (2016 - 2021)
8.1.2 India Radiopharmaceutical Revenue and Growth Rate (2016 - 2021)
8.1.3 India Radiopharmaceutical Sales Price Trend (2016 - 2021)
8.2 India Radiopharmaceutical Sales Volume and Market Share by Players (2016 - 2021)
8.3 India Radiopharmaceutical Sales Volume and Market Share by Type (2016 - 2021)
8.4 India Radiopharmaceutical Sales Volume and Market Share by Application (2016 - 2021)

9 Global Radiopharmaceutical Players/Suppliers Profiles and Sales Data
9.1 Bracco Imaging
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Radiopharmaceutical Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.1.4 Main Business/Business Overview
9.2 Bayer
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Radiopharmaceutical Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.2.4 Main Business/Business Overview
9.3 Mallinckrodt
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Radiopharmaceutical Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.3.4 Main Business/Business Overview
9.4 Nordion
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Radiopharmaceutical Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.4.4 Main Business/Business Overview
9.5 Triad Isotopes
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Radiopharmaceutical Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.5.4 Main Business/Business Overview
9.6 Lantheus
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Radiopharmaceutical Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.6.4 Main Business/Business Overview
9.7 IBA Group
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Radiopharmaceutical Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.7.4 Main Business/Business Overview
9.8 GE Healthcare
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Radiopharmaceutical Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.8.4 Main Business/Business Overview
9.9 China Isotope & Radiation
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Radiopharmaceutical Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.9.4 Main Business/Business Overview
9.10 Jubilant Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Radiopharmaceutical Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.10.4 Main Business/Business Overview
9.11 Eli Lilly
9.12 Advanced Accelerator Applications
9.13 SIEMENS
9.14 Dongcheng
9.15 Navidea

10 Radiopharmaceutical Maufacturing Cost Analysis
10.1 Radiopharmaceutical Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Radiopharmaceutical
10.3 Manufacturing Process Analysis of Radiopharmaceutical

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Radiopharmaceutical Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2020
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Radiopharmaceutical Market Forecast (2021 - 2027)
14.1 Global Radiopharmaceutical Sales Volume, Revenue and Price Forecast (2021 - 2027)
14.1.1 Global Radiopharmaceutical Sales Volume and Growth Rate Forecast (2021 - 2027)
14.1.2 Global Radiopharmaceutical Revenue and Growth Rate Forecast (2021 - 2027)
14.1.3 Global Radiopharmaceutical Price and Trend Forecast (2021 - 2027)
14.2 Global Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast by Region (2021 - 2027)
14.2.1 Global Radiopharmaceutical Sales Volume and Growth Rate Forecast by Regions (2021 - 2027)
14.2.2 Global Radiopharmaceutical Revenue and Growth Rate Forecast by Regions (2021 - 2027)
14.2.3 United States Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.4 Europe Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.5 China Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.6 Japan Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.7 Southeast Asia Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.8 India Radiopharmaceutical Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.3 Global Radiopharmaceutical Sales Volume, Revenue and Price Forecast by Type (2021 - 2027)
14.3.1 Global Radiopharmaceutical Sales Forecast by Type (2021 - 2027)
14.3.2 Global Radiopharmaceutical Revenue Forecast by Type (2021 - 2027)
14.3.3 Global Radiopharmaceutical Price Forecast by Type (2021 - 2027)
14.4 Global Radiopharmaceutical Sales Volume Forecast by Application (2021 - 2027)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures

Figure Product Picture of Radiopharmaceutical
Figure Global Radiopharmaceutical Sales Volume Comparison (M Doses) by Type (2016 - 2027)
Figure Global Radiopharmaceutical Sales Volume Market Share by Type (Product Category) in 2020
Figure Actinium - 225 Product Picture
Figure Lutetium - 177 Product Picture
Figure Radium - 223 Product Picture
Figure Holmium - 166 Product Picture
Figure Other Product Picture
Figure Global Radiopharmaceutical Sales Comparison (M Doses) by Application (2016 - 2027)
Figure Global Sales Market Share of Radiopharmaceutical by Application in 2020
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Radiopharmaceutical Market Size (Million USD) by Regions (2016 - 2027)
Figure United States Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Europe Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure China Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Japan Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Southeast Asia Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure India Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Radiopharmaceutical Sales Volume (M Doses) and Growth Rate (2016 - 2027)
Figure Global Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Market Major Players Radiopharmaceutical Sales Volume (M Doses) (2016 - 2021)
Table Global Radiopharmaceutical Sales (M Doses) of Key Players/Suppliers (2016 - 2021)
Table Global Radiopharmaceutical Sales Share by Players/Suppliers (2016 - 2021)
Figure 2020 Radiopharmaceutical Sales Share by Players/Suppliers
Figure 2020 Radiopharmaceutical Sales Share by Players/Suppliers
Figure Global Radiopharmaceutical Revenue (Million USD) by Players/Suppliers (2016 - 2021)
Table Global Radiopharmaceutical Revenue (Million USD) by Players/Suppliers (2016 - 2021)
Table Global Radiopharmaceutical Revenue Share by Players/Suppliers (2016 - 2021)
Table 2020 Global Radiopharmaceutical Revenue Share by Players
Table 2020 Global Radiopharmaceutical Revenue Share by Players
Table Global Radiopharmaceutical Sales (M Doses) and Market Share by Type (2016 - 2021)
Table Global Radiopharmaceutical Sales Share (M Doses) by Type (2016 - 2021)
Figure Sales Market Share of Radiopharmaceutical by Type (2016 - 2021)
Figure Global Radiopharmaceutical Sales Growth Rate by Type (2016 - 2021)
Table Global Radiopharmaceutical Revenue (Million USD) and Market Share by Type (2016 - 2021)
Table Global Radiopharmaceutical Revenue Share by Type (2016 - 2021)
Figure Revenue Market Share of Radiopharmaceutical by Type (2016 - 2021)
Figure Global Radiopharmaceutical Revenue Growth Rate by Type (2016 - 2021)
Table Global Radiopharmaceutical Sales Volume (M Doses) and Market Share by Region (2016 - 2021)
Table Global Radiopharmaceutical Sales Share by Region (2016 - 2021)
Figure Sales Market Share of Radiopharmaceutical by Region (2016 - 2021)
Figure Global Radiopharmaceutical Sales Growth Rate by Region in 2020
Table Global Radiopharmaceutical Revenue (Million USD) and Market Share by Region (2016 - 2021)
Table Global Radiopharmaceutical Revenue Share (%) by Region (2016 - 2021)
Figure Revenue Market Share of Radiopharmaceutical by Region (2016 - 2021)
Figure Global Radiopharmaceutical Revenue Growth Rate by Region in 2020
Table Global Radiopharmaceutical Revenue (Million USD) and Market Share by Region (2016 - 2021)
Table Global Radiopharmaceutical Revenue Share (%) by Region (2016 - 2021)
Figure Revenue Market Share of Radiopharmaceutical by Region (2016 - 2021)
Figure Global Radiopharmaceutical Revenue Market Share by Region in 2020
Table Global Radiopharmaceutical Sales Volume (M Doses) and Market Share by Application (2016 - 2021)
Table Global Radiopharmaceutical Sales Share (%) by Application (2016 - 2021)
Figure Sales Market Share of Radiopharmaceutical by Application (2016 - 2021)
Figure Global Radiopharmaceutical Sales Market Share by Application (2016 - 2021)
Figure United States Radiopharmaceutical Sales (M Doses) and Growth Rate (2016 - 2021)
Figure United States Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2021)
Figure United States Radiopharmaceutical Sales Price (USD/Dose) Trend (2016 - 2021)
Table United States Radiopharmaceutical Sales Volume (M Doses) by Players (2016 - 2021)
Table United States Radiopharmaceutical Sales Volume Market Share by Players (2016 - 2021)
Figure United States Radiopharmaceutical Sales Volume Market Share by Players in 2020
Table United States Radiopharmaceutical Sales Volume (M Doses) by Type (2016 - 2021)
Table United States Radiopharmaceutical Sales Volume Market Share by Type (2016 - 2021)
Figure United States Radiopharmaceutical Sales Volume Market Share by Type in 2020
Table United States Radiopharmaceutical Sales Volume (M Doses) by Application (2016 - 2021)
Table United States Radiopharmaceutical Sales Volume Market Share by Application (2016 - 2021)
Figure United States Radiopharmaceutical Sales Volume Market Share by Application in 2020
Figure Europe Radiopharmaceutical Sales (M Doses) and Growth Rate (2016 - 2021)
Figure Europe Radiopharmaceutical Revenue (Million USD) and Growth Rate (2016 - 2021)
Figure Europe Radiopharmaceutical Sales Price (USD/Dose) Trend (2016 - 2021)
Table Europe Radiopharmaceutical Sales Volume (M Doses) by Players (2016 - 2021)
Table Europe Radiopharmaceutical Sales Volume Market Share by Players (2016 - 2021)
Figure Europe Radiopharmaceutical Sales Volume Market Share by Players in 2020
Table Europe Radiopharmaceutical Sales Volume (M Doses) by Type (2016 - 2021)
Table Europe Radiopharmaceutical Sales Volume Market Share by Type (2016 - 2021)
Figure Europe Radiopharma

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Immediate acquisition

Your strategic edge begins with Stats and Research

Single User License

$2800

It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.

Multi User License

$3800

It allows the purchased product to be shared among 1-5 employees of your organization within same geographical location.

Enterprise User License

$4800

It allows the purchased product to be shared among all employees of your organisation irrespective of their geographical location.

Services

View All Healthcare Reports

Global Cellular Products Market

Global Blue Light Therapy Device Market

Global Artificial Intelligence Based Blood Test Market

Global Digital Pills Market

Global POC Ultrasound Market

Global Needle-Free Blood Testing Market

Global Medical Tourism Market

Gummy Supplements Market

Software As a Medical Device (SaMD) Market

Canada Consumer Healthcare Market